The way in which LRRK2 mutations cause PD is also not clear, but there is evidence that increased kinase activity of the mutated LRRK2 that can also be measured in peripheral blood cells in humans (Fan et al. 2018), may contribute to the toxicity of pathogenic LRRK2 mutants. Here, LRRK2 is linked to Parkinson disease.